Commercial and Portfolio Analysis


Develop a combined vaccine and biosimilar strategy for a start-up drug company.


  • Identify pipeline candidates
  • Research a marketing and reimbursement strategy
  • Support the development of an initial regulatory strategy
  • Initiated discussions for the in-licensing of molecules


  • Various financial models
  • A manufacturing strategy
  • A marketing and reimbursement strategy


A recommendation that the in-licensing models proposed along with the unique market and reimbursement dynamics made the business a higher risk than client originally anticipated.  Client elected not to pursue the model further.